Ex-Pharma CEO Denied 3rd Circ. Rehearing In $1M FBAR Case
By Asha Glover · September 27, 2022, 6:58 PM EDT
The Third Circuit declined Tuesday to reconsider its decision backing $1 million in penalties imposed against a former pharmaceutical CEO for failing to report his Swiss bank accounts....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login